- Market Capitalization, $K 202,894,592
- Shares Outstanding, K 2,236,739
- Annual Sales, $ 52,877 M
- Annual Income, $ 24,021 M
- 60-Month Beta 0.52
- Price/Sales 3.78
- Price/Cash Flow 9.92
- Price/Book 3.24
|Period||Period Low||Period High||Performance|
| || |
+2.72 (+3.05%)since 04/22/22
| || |
+6.25 (+7.29%)since 02/24/22
| || |
+3.91 (+4.44%)since 05/24/21
Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation (BAC), Novo Nordisk A/S (NVO), and Novartis AG (NVS).
Novartis (NVS) Cosentyx gets a positive CHMP recommendation for the indication of juvenile idiopathic arthritis.
The shares of leading baby formula maker Perrigo Company (PRGO) have been soaring in price of late amid a nationwide baby formula shortage. So, because the crisis is expected to continue through the coming...
Alnylam's (ALNY) portfolio of approved drugs is witnessing strong uptake so far while its pipeline is progressing well. However, stiff competition in the target market remains a woe.
Novartis can provide investors with a market-crushing 3.8% dividend yield -- and that isn't all the stock has to offer.
Shares of Teva Pharmaceutical (TEVA) have plunged in price due to the company’s weak financials and its reduction of its top-line guidance. However, can the stock rebound by the company leveraging its...
Despite challenging economic conditions, these companies are unlikely to cut their dividends.
If you invest in these stocks, it's likely your dividend income will increase over the years.
The market’s near-term outlook remains uncertain on concerns over the persistent macroeconomic and geopolitical issues. But we think investors worried about a market meltdown can look to add quality...
Deciphera (DCPH) reports narrower-than-expected loss in the first quarter of 2022 while revenues beat estimates.
|Novartis Ag ADR|
|Vaneck Pharmaceutical ETF|
|Intl Dividend Achievers Invesco ETF|
|Avantis International Large Cap Value ETF|
|Dimensional International Value ETF|
|Avantis Responsible International Equity ETF|
|3rd Resistance Point||93.54|
|2nd Resistance Point||92.83|
|1st Resistance Point||92.38|
|1st Support Level||91.22|
|2nd Support Level||90.51|
|3rd Support Level||90.06|